Pages
Posts by category
- Category: עדכונים
- Category: Article
- Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews (12/11/2021)
- Effects of Brexpiprazole Across Symptom Domains in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies (05/30/2021)
- Chronobiologic parameter changes in patients with major depressive disorder and sleep disturbance treated with adjunctive brexpiprazole: An open-label, flexible-dose, exploratory substudy (01/09/2021)
- Effect of Brexpiprazole on Prolactin and Sexual Functioning. An Analysis of Short- and Long-Term Study Data in Major Depressive Disorder (11/30/2020)
- Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies (07/30/2020)
- Effect of Brexpiprazole on Agitation and Hostility in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies (12/09/2019)
- Changes in Metabolic Parameters and Body Weight in Patients With Major Depressive Disorder Treated With Adjunctive Brexpiprazole: Pooled Analysis of Phase 3 Clinical Studies (10/30/2019)
- Efficacy and safety of brexpiprazole as adjunctive treatment in major depressive disorder: overview of four short-term studies (10/20/2019)
- A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder (04/09/2019)
- Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies (12/20/2018)
- Effect of Brexpiprazole on Prolactin. An Analysis of Short- and Long-Term Studies in Schizophrenia (11/15/2018)
- Changes in metabolic parameters and body weight in brexpiprazole-treated patients with acute schizophrenia: pooled analyses of phase 3 clinical studies (07/27/2018)
- Adjunctive brexpiprazole for elderly patients with major depressive disorder: An open‐label, long‐term safety and tolerability study (07/23/2018)
- Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies (12/28/2017)
- Activating and Sedating Adverse Effects of Second-Generation Antipsychotics in the Treatment of Schizophrenia and Major Depressive Disorder: Absolute Risk Increase and Number Needed to Harm (04/09/2017)
- Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study (01/09/2017)
- Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability: An Exploratory Study (12/09/2016)
- Effects of Adjunctive Brexpiprazole on Sleep Disturbances in Patients With Major Depressive Disorder: An Open-Label, Flexible-Dose, Exploratory Study (12/09/2016)
- Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment (11/09/2016)
- Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning (10/26/2016)
- Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials (09/09/2016)
- Efficacy of Adjunctive Brexpiprazole in Patients with Major Depressive Disorder: A Clinical Overview (08/30/2016)
- The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study (08/30/2016)
- Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia (07/30/2016)
- Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study (07/24/2016)
- Mechanism of action of brexpiprazole: comparison with aripiprazole (02/28/2016)
- Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator (06/19/2014)
- Category: מחקרים על MDD
- Category: מחקרים על סכיזופרניה
- Category: סרטונים והרצאות